Mihaela Roxana Cimpan

Position

Professor

Affiliation

Research
  • Biomaterials, Nanomaterials 
  • Safer and sustainable-by-design development of nano- and advanced materials
  • Development of New Approach Methodologies to evaluate the biological effects of (nano)materials
  • Bioimpedance, microfluidics, 3D biological models
  • Biological effects of biomaterials and nanomaterials, Biocompatibiltiy
  • Nanotoxicology
  • Nanomedicine

 

Teaching

dental students, dental hygienist students, specialist candidates, PhD candidates, BSc and MSc students in Nanotechnology and Nanoscience

Projects

"Theranostic exosomes in personalized cancer nanomedicine" (TEPCAN) (2020-2024) – EEA - WP leader

"Research School for Training the Next Generation of Micro- and Nanotechnology Researchers in Norway" (TNNN) (2022-2030) - Research Council of Norway - WP lead, board member 

"Metal nanoparticles contamination of milk: mother-to-young transfer and role of extracellular vesicles" (NanoMilk) (2023-2026) - ANR (INRAE lead) - WP leader

"Towards a reliable assessment of nanomaterial health effects using advanced biological models and assays" (NanoBioReal) (2019-2023) - finnanced by the Norwegian Research Coucil, NANO2021 program - coordinator

"Science-based Risk Governance of Nano-Technology" (RiskGone) (2019-2023) - finnanced by HORIZON2020 (H2020-NMBP-13-2018 RIA, grant agreement nr. 814425) - WP co-leader

COST action "Nano2Clinic" - partner (2019-2023)

"Development of impedance-based non-invasive techniques for evaluating the biological effects of nanoparticles"  - funded by UH-nett Vest - project leader

“Innovative Nanopharmaceuticals: Targeting breast cancer stem cells by a novel combination of epigenetic and anticancer drugs with gene therapy (INNOCENT)” (2017-2020) - financed by EuroNanoMed II - Principal investigator v/UiB

“Self-navigated integrin receptors seeking "thermally-smart" multifunctional few-layer graphene-encapsulated magnetic nanoparticles for molecular MRIguided anticancer treatments in "real time" personalized nanomedicine (GEMNS)” (2015 - 2018) - financed by EuroNanoMed II, through EC’s 7th Framework Programme - Principal investigator and leader of the Norwegian partners

"A common European approach to the regulatory testing of nanomaterials" NANoREG - the project is funded by the FP7 European Framework Program on Nanoscience, Nanotechnologies, materials and new production technologies (2013-2017) - Principal investigator

“National initiative towards developing a common approach to the regulatory testing of manufactured nanomaterials” (NorNANoREG) – project funded by the Norwegian Research Council, the NANO2021 program (2014-2017) - Principal investigator and task leader